CXCL12 Expression Is an Adverse Predictor for Disease Recurrence in Patients With Metastatic Non-Seminomatous Testicular Germ Cell Tumors
BMC Cancer - United Kingdom
doi 10.1186/s12885-019-5961-1
Full Text
Open PDFAbstract
Available in full text
Date
August 14, 2019
Authors
Publisher
Springer Science and Business Media LLC